Loading company
BioNexus Gene Lab Corp
BGLC · Nasdaq · ·
$1.38+1.5%Sep 29 close
- 1M
- -11.3%
- 6M
- -40.7%
- 1Y
- -74.9%
BioNexus Gene Lab Corp is the 58th largest of 60 graded companies. Showing 5 of them, including BGLC itself. 1 more is in this industry but has no grade yet, so it is left out rather than shown blank.
| Company | Grade | Market value | Revenue | Profit margin | Free cash flow | Price to earnings |
|---|---|---|---|---|---|---|
| Linde plcLIN | C+ | $218.2B | $35.4B | 20.4% | $5B | 30.55 |
| The Sherwin-Williams CompanySHW | A+ | $80.2B | $24.4B | 11.0% | $3.2B | 30.45 |
| Ecolab Inc.ECL | B+ | $77.9B | $16.8B | 12.6% | $1.9B | 37.30 |
| AIR Products And Chemicals, Inc.APD | F- | $62.2B | $12.6B | -0.4% | -$3.8B | — |
| BioNexus Gene Lab Corp.BGLC | F- | $4M | $3.1M | -82.4% | -$853.6K | — |
55 more specialty chemicals companies
Graded on the same five checks, from their own SEC filings.
A blank price-to-earnings means a loss, not a missing figure — the ratio has no meaning when there are no earnings to divide by, and printing a negative one would make the least profitable company look the cheapest.
Grades are trailing twelve months from each company’s own SEC filings, so they move only when a company files. Every column is computed by the same code that graded BioNexus Gene Lab Corp on the overview — nothing here comes from a data vendor’s own ratios.
Industry membership is not a judgement about how similar two businesses are. It groups companies by what they are classified as, which is a starting point for comparison rather than a claim that they compete.
BGLC · Nasdaq · ·
$1.38+1.5%Sep 29 close